Hsbc Holdings PLC Acadia Pharmaceuticals Inc Transaction History

Hsbc Holdings PLC

$176 Billion
Q3 2025

A detailed history of Hsbc Holdings PLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 30,791 shares of ACAD stock, worth $739,599. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,791

Previous 38,631 20.29%

Holding current value

$739,599

Previous $833,000 21.13%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$20.88 - $26.57 $163,699 - $208,308	-7,840 Reduced 20.29%	30,791 $657,000
Q2 2025 Aug 13, 2025	SELL	$14.1 - $22.95 $348,072 - $566,543	-24,686 Reduced 38.99%	38,631 $833,000
Q1 2025 May 14, 2025	SELL	$16.61 - $20.29 $94,743 - $115,734	-5,704 Reduced 8.26%	63,317 $1.05 Million
Q4 2024 Feb 14, 2025	BUY	$14.29 - $18.76 $57,517 - $75,509	4,025 Added 6.19%	69,021 $1.27 Million
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $778,922 - $984,714	51,448 Added 379.75%	64,996 $1 Million

Q2 2024 Aug 12, 2024	BUY	$14.62 - $18.42 $5,950 - $7,496	407 Added 3.1%	13,548 $220,000
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $233,778 - $405,531	13,141 New	13,141 $242,000
Q2 2022 Aug 11, 2022	SELL	$13.01 - $27.22 $29,597 - $61,925	-2,275 Reduced 17.72%	10,566 $149,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $268,890 - $353,127	12,841 New	12,841 $314,000
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $434,944 - $682,735	-27,563 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$19.4 - $27.42 $123,054 - $173,925	6,343 Added 29.89%	27,563 $0
Q1 2021 May 14, 2021	BUY	$25.02 - $54.99 $369,495 - $812,092	14,768 Added 228.89%	21,220 $0
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $452,999 - $626,848	-11,038 Reduced 63.11%	6,452 $0
Q3 2020 Nov 12, 2020	SELL	$36.42 - $57.0 $133,843 - $209,475	-3,675 Reduced 17.36%	17,490 $720,000
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $617,481 - $829,337	15,728 Added 289.28%	21,165 $1.03 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $395,371 - $585,500	-12,492 Reduced 69.67%	5,437 $230,000
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $361,013 - $512,458	9,970 Added 125.27%	17,929 $762,000
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $176,848 - $350,275	7,959 New	7,959 $286,000
Q2 2019 Aug 13, 2019	SELL	$23.32 - $28.12 $184,134 - $222,035	-7,896 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $127,678 - $216,192	7,896 New	7,896 $212,000
Q1 2018 May 11, 2018	SELL	$22.47 - $32.33 $304,625 - $438,297	-13,557 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $363,869 - $530,620	13,557	13,557 $408,000

Others Institutions Holding ACAD

# of Institutions

373

Shares Held

162M

Call Options Held

1.46M

Put Options Held

1.09M

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.89B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Acadia Pharmaceuticals Inc Transaction History